Found 56 matching trials
A Phase II Study of AK146D1 in Combination With AK112 in Advanced Non-Small Cell Lung Cancer PHASE2 This is a phase II clinical study evaluating the safety, tolerability, phar...
Show More Location
SunYat-sen University Cancer Center
Learn More & Join Trial
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma N/A This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Show More Location
The Second Affiliated Hospital of Fujian Medical University
Learn More & Join Trial
Safety and Efficacy of Yiwoxidan Anti (AK112) Monotherapy in Patients With Metastatic Renal Clear Cell Carcinoma Who Are Intolerant to TKI Treatment: a Prospective, Single Arm, Phase II Clinical Study PHASE2 This study is testing a new medicine called AK112 (Yivoximab) for people wi...
Show More Status
Enrolling By Invitation
Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Study of IBI3005 Combination Therapy in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors PHASE1 To evaluate the safety and tolerability of IBI3005 combination therapy in p...
Show More Location
SunYat-sen University Cancer Center
Learn More & Join Trial
A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer PHASE2 This is a prospective, multi-center, open-label, single-arm, non-randomized...
Show More Location
University of South Alabama / Mitchell Cancer Institute Univ South Alabama
Learn More & Join Trial
A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034) PHASE3 Researchers are looking for new ways to treat advanced renal cell carcinoma...
Show More Location
Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital ( Site 0102)
Learn More & Join Trial
Efficacy and Safety of Apatinib for Recurrent or Metastatic Esophageal Squamous Cell Carcinoma PHASE2 There is no standard treatment strategy for recurrent or metastatic esophag...
Show More Location
Shanghai Yangpu District East Hospital
Learn More & Join Trial
A Study of Vemurafenib (RO5185426) in Participants With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation PHASE2 This open-label, multi-center study will evaluate the safety and efficacy o...
Show More Location
Multiple Locations
Learn More & Join Trial
Quality of Life Assessment in Daily Clinical Oncology Practice for Patients With Advanced Renal Cell Carcinoma NA Physician mainly use RECIST progression-free survival (PFS) and NCI CTCAE s...
Show More Learn More & Join Trial
RegoNivo vs Standard of Care Chemotherapy in AGOC PHASE3 To determine if the regorafenib and nivolumab combination (RegoNivo) improv...
Show More Location
Mayo Clinic Arizona
Learn More & Join Trial